Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
8
×
startups
8
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
deals
new york blog main
new york top stories
san francisco blog main
vc
boston
clinical trials
san diego blog main
san diego top stories
san francisco top stories
biogen
drug discovery
financing
glaxosmithkline
investing
ipo
ptc therapeutics
raleigh-durham blog main
raleigh-durham top stories
third rock ventures
venture capital
accent therapeutics
acetylon pharmaceuticals
aducanumab
allosteric
alnylam
alnylam pharmaceuticals
alzheimer's disease
amblyotech
ambys medicines
antisense oligonucleotide
arena pharmaceuticals
artie suckow
What
medicines
8
×
new
8
×
drugs
biotech
developing
research
adds
aims
called
disease
diseases
drug
molecules
startup
targets
therapeutics
years
activity
address
advance
ago
aiming
algorithms
alliance
allosteric
ambys
approach
approvals
areas
backed
based
batch
big
bio
biogen
biologics
biosciences
bio’s
bottlenecks
brii
Language
unset
Current search:
new
×
biotech
×
medicines
×
startups
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks